Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1
Audrey Sabbagh(Université Paris Cité), P. Wolkenstein(Université Paris-Est Créteil), Éric Pasmant(Centre National de la Recherche Scientifique), S. Barbarot(Hotel Dieu Hospital), Michel Vidaud(Institut de Soudure), S. Ferkal(Lyon 1 Université), B. Guillot(Université de Montpellier), P. Combemale(Centre Léon Bérard), Dominique Vidaud(Inserm), Patrick Aubourg(Inserm), Ingrid Laurendeau(Délégation Paris 5), Béatrice Parfait(Délégation Paris 5)
Cited by 147
Related Papers
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592